Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Portal Hypertension
What is your endoscopic approach to the management of refractory GAVE in persistently anemic patients?
Related Questions
Who would be the right candidate in which TIPS placement would reduce portal hypertension to allow for a previously unattainable procedure?
What clinical evidence do you find most favorable of a positive response post-liver transplant for patients with portopulmonary hypertension?
What clinical scenario would you favor NOT using terlipressin for the management of HRS if there were no notable contraindications for its initiation?
What is your approach to the management of post-TIPS hepatic encephalopathy?
How do you utilize urine sodium and potassium levels and ratios in diuretic optimization in patients with ascites?
What are your clinical considerations to pursue an automated-low-flow ascites (ALFA) pump for a patient with refractory ascites?
What patient clinical factors do you find most impact a patient's "beta-blocker window" and their ability to maintain and tolerate beta-blocker therapy?
What role do you see for albumin infusions in patients with hypoalbuminemia to help assist in volume status, outside of its use in replenishment after a large volume paracentesis or renal dysfunction?
When would you choose to measure a patient's spleen stiffness?
Do you recommend the use of SGLT2 inhibitors to reduce the risk of liver cirrhosis in patients with Type 2 diabetes mellitus?
